日本市场个股详情
4502 武田制药
- 4083.0
- -20.0-0.49%
延时20分钟行情休市中 11/29 15:30 (东京)
6.50万亿总市值44.79市盈率(静)
4100.0最高价4075.0最低价261.14万股成交量4093.0今开4103.0昨收106.66亿成交额4494.052周最高0.17%换手率15.91亿总股本3852.052周最低181.98每股收益TTM6.19万亿流通值8080.0历史最高44.79市盈率(静)15.17亿流通股2894.5历史最低91.16每股收益(静)0.61%振幅192.00股息TTM0.94市净率100股每手4.70%股息率TTM
关于武田制药公司
武田药品工业是日本最大的制药公司，2023财年的收入为4.3万亿日元。该公司的五大核心治疗领域是肿瘤学、胃肠病学、神经科学、罕见病和血浆衍生疗法，占收入的80%以上。它的地域分布非常多元化，其中50%来自美国，20%来自日本，20%来自欧洲和加拿大。
公司介绍
公司代码4502
公司名称武田制药
成立日期1925-01-29
所属市场东证Prime
员工数量49281
年结日03-31
公司地址1-1, Nihonbashi-Honcho 2-Chome Chuo-ku
邮编540-8645
电话06-6204-2111
董事高管
- 姓名
- 职务
- 年薪
- Akiko Amakawa
- Corporate Strategy Officer and Chief Executive Officer Chief of Staff
- --
- Christophe Weber
- Director, President and Chief Executive Officer; Head of Global Business of Takeda Pharmaceuticals U.S.a., Inc.
- 17.02亿
- Mwana Lugogo
- Chief Ethics and Compliance Officer
- --
- Milano Furuta
- Director and Chief Financial Officer
- --
- Gabriele Ricci
- Chief Data and Technology Officer
- --
- Lauren Duprey
- Chief Human Resources Officer
- --
- Takako Ohyabu
- Chief Global Corporate Affairs and Sustainability Officer
- --
- Dr. Thomas Wozniewski, PhD
- Global Manufacturing and Supply Officer
- --
- Elaine Shannon
- Global Quality Officer
- --
- Marcello Agosti
- Global Business Development Officer
- --
- Asuka Miyabashira
- President, Japan Pharma Business Unit
- --
- Julie Kim
- President, U.S. Business Unit and U.S. Country Head
- --
- Andrew S. Plump, M.D.
- Director and President, Research and Development
- 1200.00万
- Ramona Sequeira
- President, Global Portfolio Division
- --
- Teresa Marie Bitetti
- President, Global Oncology Business Unit
- --
- Giles Platford
- President, Plasma-Derived Therapies Business Unit
- --
- Masami Iijima
- Chairman of the Board
- 4300.00万
- Dr. John M. Maraganore,PhD
- Independent Director
- 3900.00万
- Emiko Higashi
- Independent Director
- 4900.00万
- Miki Tsusaka
- Independent Director
- 3200.00万
- Kimberly A. Reed
- Independent Director
- 4100.00万
- Jean-Luc Butel
- Independent Director
- 3800.00万
- Michel Orsinger
- Independent Director
- 4600.00万
- Dr. Steven Gillis, Pd.D
- Independent Director
- 4400.00万
- Koji Hatsukawa
- Independent Director
- 4300.00万
- Ian T. Clark
- Independent Director
- 4400.00万
- Yoshiaki Fujimori
- Independent Director
- 4000.00万
- Yoshihiro Nakagawa
- Global General Counsel
- --
分析
目标价预测
暂无数据
热议
日股
综合热度
股票代码
最新价
涨跌幅
暂无数据